Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET research.
RET Research News and Information
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials
RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)
RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
Cancer Cell Lines: Consider Donating to Advance Research
Cancer Cell Lines: Consider Donating to Advance Research
2025 IASLC Targeted Therapies Recap
2025 IASLC Targeted Therapies Recap
A Legacy of Hope in the Fight Against Lung Cancer
A Legacy of Hope in the Fight Against Lung Cancer
Announcing Lung Cancer Genetics Study & Lifebit Partnership
Announcing Lung Cancer Genetics Study & Lifebit Partnership
Lung Cancer Risk Factors: Understanding its Causes and Prevention
Lung Cancer Risk Factors: Understanding its Causes and Prevention
Why Donate to Lung Cancer Research?
Why Donate to Lung Cancer Research?
Navigating The Lung Cancer Clinical Trial Enrollment Process
Navigating The Lung Cancer Clinical Trial Enrollment Process
Boosting Research: The Role of Lung Cancer Registries for RET-Positive Lung Cancer Patients
Boosting Research: The Role of Lung Cancer Registries for RET-Positive Lung Cancer Patients
2024 RET Cancer Research Update
2024 RET Cancer Research Update
Cracking the Code: What RET Gene Alteration Means for Your Lung Cancer
Cracking the Code: What RET Gene Alteration Means for Your Lung Cancer
Get to Know Irene, our Director of Research
Get to Know Irene, our Director of Research
The 4 Stages of Non-Small Cell Lung Cancer (NSCLC)
